Test 2 Cardiac Drugs Flashcards
1
Q
atropine: nursing implications
A
- contraindicated in pts with glaucoma, tachycardia, urinary tract obstruction
- moisten mouth before administration
- wear sunglasses outdoors
- void before taking meds to avoid urinary retention
- can avoid constipation by taking a laxative and inc dietary fiber/fluids
- avoid vigorous exercise in warm environment
2
Q
digoxin: class
A
- antidysrhythmic
- cardiac glycoside
- inotropic
3
Q
dronedarone: ADRs
A
- liver toxicity
- in pts with severe HF or permanent atrial fibrillation, doubles risk of death
- pulmonary fibrosis, pneumonitis
- bradycardia
- heart block
- renal failure
- angioedema
4
Q
adenosine: ADRs
A
- sinus bradycardia
- seizures
- stroke
- MI
- ventricular tachycardia
5
Q
adenosine: SE
A
- dyspnea (from bronchoconstriction)
- hypoTN
- facial flushing (from vasodilation)
- chest comfort (from stimulation of pain receptors in the heart)
6
Q
diltizem: ADRs
A
- bradycardia
- AV block
- heart failure
- can exacerbate heart dysfunctions
7
Q
pravastatin: MOA
A
- decrease LDL cholesterol
-
can also slightly inc HDL cholesterol
- mechanism depends on number of LDL receptors on the liver cells
- inhibits hepatic HMG CoA reductase which is the enzyme in cholesterol synthesis
- b/c there is then dec cholesterol production, liver cells make more HMG CoA reductase, so then cholesterol synthesis is restored to pretreatment levels
- but, inhibition of cholesterol synthesis makes liver cells synthesize more LDL receptors, so it then can remove more LDLs from the blood
- mechanism depends on number of LDL receptors on the liver cells
8
Q
amiodarone: class
A
- antidysrhythmic
- potassium channel blocker (class III)
9
Q
atropine: class
A
- antidysrhythmic
- anticholinergic
- antimuscarinic
10
Q
Adenosine: changes to EKG
A
- prolongs PR interval b/c of delayed AV conduction
11
Q
dronedarone: SE
A
- diarrhea
- weakness
- nausea
- skin rxns
- sensitivity to light’
- abdominal pain
12
Q
adenosine: nursing implications
A
- ADRs/SEs are minimal and last less than 1 minute b/c the drug is cleared rapidly from the blood
- asthma pts taking certain meds (ie. theophylline) need a larger dose of adenosine b/c those meds block adenosine Rs and even then the adenosine may not work
- short half life (<10 sec), so must give by IV bolus
- watch for orthostatic hypoTN and bronchospasm in asthmatics
- 6 second flat line
- hold arm above pt when administer
13
Q
amiodarone: indications (IV)
A
- tx and prophylaxis of recurrent ventricular fibrillation
- hemodynamically unstable ventricular tachycardia
- unapproved uses:
- atrial fibrillation
- AV nodal reentrant tachycardia
- shock resistant ventricular fibrillation
14
Q
atropine: ADRs
A
- elevation of intraocular pressure
- urinary retention
- tachycardia
15
Q
diltizem: indications
A
-
atrial fibrillation w/ RVR or flutter
- b/c slow ventricular rate
- AV nodal reentrant circuit
- so terminates SVT
- essential HTN
- angina pectoris
- NOT effective against ventricular dysrhythmias
16
Q
digoxin: ADRs
A
- cardiotoxicity: dysrhythmias
- risk inc by hypokalemia which can result from concurrent therapy with diuretics (thiazides and loop diuretics)
- risk inc by presence of heart dz
17
Q
diltizem: SEs
A
- vasodilation–>hypoTN and peripheral edema, facial flushing, headache, dizziness
- constipation, but LESS than verapamil
- chronic eczematous rash in older adults
18
Q
verapamil: class
A
- antidysrhythmic
- nondihydropyridine calcium channel blocker (class IV)
19
Q
amiodarone: nursing implications (PO)
A
- contraindicated for pts w/ severe sinus node dysfunction, 2nd/3rd degree heart block, pregnant women, preexisting HF
- very toxic so only give to pts who haven’t responded to safer drugs
- toxicity can continue for weeks or months after withdrawal, so patient must be given medication guide
- baseline chest x ray and pulmonary fcn
- monitor throughout therapy
- baseline thyroid fcn
- monitor throughout therapy
- baseline liver fcn
- monitor throughout therapy
- do not give to pregnant women or women who are breast feeding b/c lipid soluble (so crosses placenta and enters breast milk)
- avoid sunlamps, wear sunscreen
- do NOT consume grapefruit juice, b/c can cause toxicity
- report any signs of changes in visual acuity
20
Q
digoxin: SEs
A
- GI disturbances: anorexia, nausea, vomiting, discomfort
- CNS: fatigue, visual disturbances
21
Q
digoxin: changes to EKG
A
- prolonged PR interval
- shorted QT
- depressed ST segment
- T wave is depressed or inverted
22
Q
verapamil: ADRs
A
- bradycardia
- AV block
- heart failure
- can exacerbate heart dysfunctions
23
Q
pravastatin: class
A
- HMG CoA Reductase inhibitor
- statin
- lipid lowering agent
24
Q
pravastation: indications
A
- hypercholesterolemia: lower LDL
- primary and secondary prevention of CV events: MI, stroke, angina
- can reduce in ppl who have never had one: primary
- can reduce risk of second event: secondary
- post MI therapy: begin as soon as patient is stabilized
- diabetes: anyone over 40 yo and with LDL greater than 100
25
atropine: MOA
* competitive blockade of muscarinic Rs
* no direct effects of its own, but all result from preventing receptor activation by endogenous acetylcholine
* heart: inc HR
* exocrine glands: dec secretion
* smooth muscle: relaxation of bronchi, dec tone of GI tract
* eyes: mydriasis (dilation)
* CNS: excitation
26
verapamil: indications
* atrial fibrillation w/ RVR or flutter
* b/c slow ventricular rate
* AV nodal reentrant circuit
* so terminates **SVT**--**more long term than adenosine**
* essential HTN
* angina pectoris
* NOT effective against ventricular dysrhythmias
27
adenosine: class
* antidysrhythmic
* naturally occurring nucleotide
28
digoxin: MOA
* positive inotropic actions: their ability to inc myocardial contractile force
* can inc CO
* works by inhibiting Na/K ATPase, so inhibits the uptake of K into the cell which inhibits Na moving out, so w/ each action potential, intracellular K declines, Na inc, and Ca inc, so promotes Ca accumulation in myocytes
* dec conduction thru AV node by:
* direct depressant effect on AV node
* acting on CNS to inc parasympathetic impulses to AV node
* dec automaticity of SA node by :
* inc parasympathetic traffic to node
* dec sympathetic traffic
29
atropine: SEs
* dry mouth (xerostomia)
* can cause infections, impede swallowing
* blurred vision and photophobia
* drowsiness
* constipation
* anhidrosis
* asthma
30
dronedarone: class
* antidysrythmic
* potassium channel blocker (class III)
31
metoprolol: MOA
* **selective blockade of beta 1 receptors** in the heart
* only binds to beta 2 with a large dose
* **reduces HR**
* **reduces force of contraction**
* **reduces conduction velocity through AV node**
* reduces secretion of renin by kidney
* lowers BP
32
dronedarone: changes to EKG
* PR and QT prolongation
* widening of QRS complex
33
pravastatin: nursing implications
* contraindicated in pts with **viral or alcoholic hepatitis** and pregnant women
* **do not give to a pt with a liver problem, b/c this drug works in the liver**
* category X
* take in the evening
* **Liver fcn tests** should be done before tx and during tx
* if muscle pain develops, look at thyroid fcn
* measure creatinine kinase levels
* have lactic acid levels checked
34
dronedarone: nursing implications
* teach pts signs of liver toxicity: anorexia, nausea, vomiting, malaise, fatigue, itching, jaundice, dark urine
* cannot use in pregnancy b/c proven teratogen
* category X
* do NOT consume grapefruit juice
35
amiodarone: indications (PO)
* long term therapy of recurrent ventricular fibrillation
* recurrent hemodynamic unstable ventricular tachycardia
* atrial fibrillation
* most effective drug for this even though not approved for this use
36
metoprolol: ADRs
* **bradycardia**
* HF
* pulmonary edema
* AV heart block
* rebound cardiac excitement with abrupt withdrawal
37
dronedarone: Indications
* **atrial flutter, fibrillation**
* **also give to pts in sinus rhythm with a history of paroxysmal or persistent afib**
38
metoprolol: SEs
* reduced cardiac output
* fatigue
* weakness
39
diltizem: MOA
* blocks Ca channel blockers in the heart and blood vessels
* slowing of SA nodal automaticity
* delay of AV nodal conduction
* reduction of myocardial contractility
* blockade of peripheral arterioles which causes dilation and reduces arterial pressure
* blockade of arteries and arterioles which inc coronary perfusion
* vasodilation
40
digoxin: nursing implications
* **watch K+ levels especially in pts taking thiazide or loop diuretics**
* must be w/in normal ranges: 3.5-5.0 mEq/L
* **need to monitor these--digoxin toxicity**
* **narrow therapeutic range, so need to keep range b/w 0.5-0.8 ng/mL**
* **half life is 36-48 hours**
* make sure pts don't double up on doses to compensate for missed dose
* limit salt intake to 1500 mg/day
* pts should avoid excess fluid
* if drink alcohol, consume no more than 1 drink/day
* help pts establish appropriate regular, mild exercise
* teach pt to monitor pulse
* HR must be over 60 bpm before administration
* teach pt to monitor for signs of hypokalemia (muscle weakness)--inform doctor
41
digoxin: indications
* **HF**
* control of dysrhythmias
* **SVT**
* atrial fibrillation/flutter: can slow ventricular rate by reducing atrial impulses thru AV node
* **ineffective against ventricular dysrhythmias**
42
adenosine: Indication
* termination of paroxysmal SVT--**more emergent use**
* including Wolff Parkinson White Syndrome
* test drug during stress test in cardiac cath lab
43
verapamil: changes to EKG
* prolong PR interval
* reflect delayed AV nodal conduction
44
metoprolol: indications
* HTN--primary use for metoprolol
* angina pectoris
* HF
* MI and post MI
45
amiodarone: SE (PO)
* dyspnea
* cough
* corneal microdeposits
* photosensitivity
* CNS effects: ataxia, dizziness, tremor, hallucinations, mood alterations
* GI disturbances: nausea, vomiting, anorexia
46
difference b/w dronedarone and amiodarone
* dronedarone is less toxic but also less effective than amiodarone
* dronedarone doubles the risk of death in patients with permanent atrial fibrillation or HF
* dronedarone has shorter half life so ADRs resolve more quickly
* dronedarone DOES NOT cause thyroid, pulmonary, or ocular toxicity
47
diltizem: nursing implications
* contraindications: severe hypoTN, sick sinus syndrome, 2nd/3rd degree AV heart block
* check BP, pulse, liver & kidney fcn before starting
* **need to watch pts that are receiving diltizem with digoxin or a beta blocker**
* can be given PO or IV, but PO undergoes extensive metabolism on first pass thru liver
* do NOT consume grapefruit juice
* **monitor BP**--b/c this drug will dec BP
* inform pts about signs of cardiac effects and edema
* tell pts that constipation can be minimized by inc fluids and fiber
48
atropine: indication
* preanesthetic medication:
* sometimes procedures that stimulate baroreceptors will cause bradycardia, but since muscarinic Rs on heart, we can prevent this dangerous reduction in HR
* disorders of eye: by blocking muscarinic Rs, it can cause mydriasis and paralysis of ciliary M
* **bradycardia:** will accelerate HR in pts with bradycardia, b/c blockade of muscarinic Rs reverses parasympathetic slowing of heart
* intestinal hypertonicity and hypermotility
* muscarinic agonist poisoning
* treats **AV heart block**
49
amiodarone: changes to EKG (PO)
* widen QRS complex
* prolong PR interval
50
amiodarone: ADRs (PO)
* lung damage (biggest concern)
* hypersensitivity pneumonitis
* interstitial/alveolar pneumonitis
* pulmonary fibrosis
* paradoxical inc in dysrhythmic activity
* sinus bradycardia
* AV block
* HF
* hypo/hyperthyroidism
* liver injury: malaise, dark urine, fatigue, jaundice
* optic neuropathy
* neuritis
51
verapamil: MOA
* slowing of SA nodal automaticity
* delay of AV nodal conduction
* reduction of myocardial contractility
* blockade of peripheral arterioles which causes dilation and reduces arterial pressure
* blockade of arteries and arterioles which inc coronary perfusion
* vasodilation
52
diltizem: class
* antidysrhythmic
* nondihydropyridine calcium channel blocker (class IV)
53
pravastatin: ADRs
* myopathy/rhabdomyolysis
* can cause muscles to deteriorate
* **hepatotoxicity**
* new onset diabetes
* cataracts
54
verapamil: nursing implications
* contraindications: severe hypoTN, sick sinus syndrome, 2nd/3rd degree AV heart block
* check BP, pulse, liver & kidney fcn before starting
* **can inc risk of digoxin toxicity**--so watch K+ levels
* if combine with beta blocker, it will inc risk of bradycardia, AV block, HF
* can be given PO or IV, but PO undergoes extensive metabolism on first pass thru liver
* do NOT consume grapefruit juice
* **monitor BP**
* inform pts about signs of cardiac effects and edema
* tell pts that constipation can be minimized by inc fluids and fiber
55
pravastatin: SEs
* headache
* rash
* GI: cramps, dyspepsia, flatulence, constipation, pain
56
dronedarone: MOA
* blocks cardiac potassium channels so delays repolarization
* can block Na channels, beta adrenergic receptors, and calcium channels
57
metoprolol: class
* anti HTN
* beta blocker--only acts on the heart
58
amiodarone: MOA (PO)
* delays repolarization so prolongs action potential and ERP
* effects may be due to blockage of potassium channels
* reduced automaticity of SA node
* reduced contractility
* reduced conduction velocity of AV node, ventricles, His Purkinje fibers
* promote dilation in coronary and peripheral blood vessels
59
verapamil: SEs
* vasodilation--\>hypoTN and peripheral edema, facial flushing, headache, dizziness
* constipation
60
metoprolol: nursing implications
* contraindicated in pts with bradycardia and AV block greater than 1st degree
* be careful in pts with HF
* masks signs of hypoglycemia so watch for hunger, fatigue, poor concentration
* caution in pts with asthma, bronchospasm, diabetes
* do not d/c abruptly
* warn pt about signs of orthostatic hypoTN
61
dronedarone: contraindications
* class IV HF OR class II or III HF with recent decompensation requiring hospitalization
* liver/lung toxicity
* permanent atrial fibrillation
* 2nd/3rd degree AV block or sick sinus syndrome (unless pt has pacemaker)
* bradycardia
* PR interval greater than 280 msec
* QT interval greater than 500 msec
* use of drugs or supplements that prolong QT interval
* use of strong inhibitors of CYP34A
* pregnancy
* breast feeding
* severe liver impairment
62
adenosine: MOA
* decreases automaticity of SA node and slows conduction thru AV node
* inhibits cyclic AMP induced calcium influx, so suppresses calcium dependent action potentials in the SA and AV nodes